Genetic mouse models of Parkinson's disease The state of the art

Iddo Magen1, Marie-Françoise Chesselet

  • 1Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.

Insights

Genetically altered mouse models offer insights into Parkinson's disease (PD) mechanisms and preclinical therapy testing. Researchers are evaluating these models to understand PD's complex pathology in the mammalian brain.

Area of Science:

  • Neuroscience
  • Genetics
  • Pharmacology

Background:

  • Familial Parkinson's disease (PD) is linked to specific genetic mutations.
  • Multiple mouse models have been developed to mimic these PD-associated genetic alterations.

Purpose of the Study:

  • To review and compare various mouse models of genetic Parkinson's disease.
  • To highlight their utility in understanding PD pathophysiology and preclinical drug testing.

Main Methods:

  • Analysis of existing literature on genetically modified mouse models of PD.
  • Comparative assessment of how different models recapitulate PD symptoms and pathology.

Main Results:

  • Various mouse lines exhibit different degrees of success in modeling PD.
  • These models provide valuable platforms for investigating disease mechanisms.
  • Key findings from studies using these models are discussed.

Conclusions:

  • Genetically engineered mouse models are crucial tools for Parkinson's disease research.
  • They facilitate the study of PD pathogenesis and the evaluation of potential therapeutic interventions.

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...